Cardiol Therapeutics Inc (CRDL)
2.615
+0.04
(+1.75%)
USD |
NASDAQ |
May 31, 16:00
2.62
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Enterprise Value: 159.28M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 159.28M |
| May 30, 2024 | 156.18M |
| May 29, 2024 | 144.45M |
| May 28, 2024 | 140.65M |
| May 24, 2024 | 141.00M |
| May 23, 2024 | 132.72M |
| May 22, 2024 | 129.27M |
| May 21, 2024 | 132.03M |
| May 20, 2024 | 129.27M |
| May 17, 2024 | 128.58M |
| May 16, 2024 | 141.69M |
| May 15, 2024 | 138.93M |
| May 14, 2024 | 129.27M |
| May 13, 2024 | 127.68M |
| May 10, 2024 | 124.95M |
| May 09, 2024 | 129.73M |
| May 08, 2024 | 115.39M |
| May 07, 2024 | 114.03M |
| May 06, 2024 | 116.76M |
| May 03, 2024 | 114.71M |
| May 02, 2024 | 114.03M |
| May 01, 2024 | 119.49M |
| April 30, 2024 | 116.07M |
| April 29, 2024 | 99.69M |
| April 26, 2024 | 101.05M |
| Date | Value |
|---|---|
| April 25, 2024 | 104.47M |
| April 24, 2024 | 99.01M |
| April 23, 2024 | 104.47M |
| April 22, 2024 | 99.01M |
| April 19, 2024 | 99.69M |
| April 18, 2024 | 92.86M |
| April 17, 2024 | 98.32M |
| April 16, 2024 | 96.28M |
| April 15, 2024 | 101.05M |
| April 12, 2024 | 105.83M |
| April 11, 2024 | 112.66M |
| April 10, 2024 | 106.52M |
| April 09, 2024 | 109.93M |
| April 08, 2024 | 107.20M |
| April 05, 2024 | 108.56M |
| April 04, 2024 | 118.12M |
| April 03, 2024 | 104.47M |
| April 02, 2024 | 102.42M |
| April 01, 2024 | 109.93M |
| March 28, 2024 | 91.96M |
| March 27, 2024 | 91.30M |
| March 26, 2024 | 92.61M |
| March 25, 2024 | 69.08M |
| March 22, 2024 | 70.39M |
| March 21, 2024 | 73.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.01M
Minimum
Nov 09 2022
191.41M
Maximum
Oct 20 2021
53.88M
Average
50.80M
Median
Dec 03 2020
Enterprise Value Benchmarks
| Acasti Pharma Inc | 0.5379M |
| Aurinia Pharmaceuticals Inc | 424.68M |
| Edesa Biotech Inc | 11.48M |
| Lexaria Bioscience Corp | 45.09M |
| Xenon Pharmaceuticals Inc | 2.175B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.806M |
| Total Expenses (Quarterly) | 6.232M |
| EPS Diluted (Quarterly) | -0.1038 |
| Earnings Yield | -13.32% |